secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0000105770-25-000022
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma SVP & Chief Commercial Officer departs; severance agreed
--------------------------------------------------------------------

- Cindy Reiss-Clark left as SVP and Chief Commercial Officer on March 7, 2025.
- Severance includes 52-week salary continuation ($489,500), pro-rated AIP ($57,526), and $15K outplacement.
- Agreement includes a full release, noncompetition, nonsolicitation, and nondisparagement covenants.
- Equity vesting ends March 7, 2025; 2024 AIP bonus of $42,476 to be paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000022/0000105770-25-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577025000022/wst-20250409.htm
  HTML page:      https://secwatch.observer/filing/0000105770-25-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer